TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Durabilis Bio Solutions AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,035
|
1,076
|
1,600 |
| Financial expenses |
14
|
10
|
15 |
| Earnings before taxes |
-439
|
-592
|
-550 |
| EBITDA |
-297
|
-442
|
-451 |
| Total assets |
832
|
1,049
|
1,737 |
| Current assets |
383
|
500
|
1,023 |
| Current liabilities |
570
|
357
|
305 |
| Equity capital |
262
|
549
|
1,242 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
6
|
6
|
9 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
31.5%
|
52.3%
|
71.5% |
| Turnover per employee |
172
|
179
|
178 |
| Profit as a percentage of turnover |
-42.4%
|
-55.0%
|
-34.4% |
| Return on assets (ROA) |
-51.1%
|
-55.5%
|
-30.8% |
| Current ratio |
67.2%
|
140.1%
|
335.4% |
| Return on equity (ROE) |
-167.6%
|
-107.8%
|
-44.3% |
| Change turnover |
-45
|
-394
|
1,177 |
| Change turnover % |
-4%
|
-27%
|
278% |
| Chg. No. of employees |
0
|
-3
|
3 |
| Chg. No. of employees % |
0%
|
-33%
|
50% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.